About
Mission
Connection to Lupus Research Alliance
Leadership & Board
Contact Lupus Therapeutics
Patient & Community Engagement
Patient Advisory Boards
Patient Protocol Review Council
Peer-to-Peer Education
Community-Based Initiatives
Clinical Care & Clinical Trials
Lupus Therapeutics Healthcare Provider Directory™
Clinical Trials
Phases of Clinical Development
Clinical Research Partners
Current Collaborations and Initiatives
Advisory & Consulting Services
Clinical Research Services
LuCIN
Newsroom
NEWSROOM
Press Releases
In the News
Logo & Resources Library
Recent News
News Update
Statement in Response to Recent Lupus Science and Medicine Publication
July 16, 2024
A study recently published in Lupus Science and Medicine showed that krill oil concentrate helped to increase Omega-3 deficiency...
News Update
On “Lupus Call to Action Day”, the Lupus Research Alliance and Lupus Therapeutics Amplify a Call for Equity and Inclusion
May 1, 2024
As part of Lupus Awareness Month, May 1 has been declared “Lupus Call to Action Day” by the National...
News Update
Lupus Peer-to-Peer Early Education Program Expands
March 28, 2024
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly...
Press Release
Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics
March 14, 2024
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on...
News Update
Summary Highlights of Important Research Presented at ACR Convergence 2023
November 29, 2023
At the recent ACR Convergence 2023, the annual meeting of the American College of Rheumatology, important lupus clinical trial...
News Update
Positive One-Year Results of PALS Program Published in Prestigious Rheumatology Journal
October 27, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share that the successful results...
Press Release
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis
October 17, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced a partnership with Nkarta, Inc. (Nasdaq:...
Press Release
Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network
October 24, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announces a partnership with AbbVie Inc. for the...
News Update
Lupus Therapeutics PALS Program Expansion
October 1, 2023
Call for Individuals to Serve as a Trained Peer Educator Lupus Therapeutics, the clinical affiliate of Lupus Research Alliance, is...
Press Release
Project CHANGE Launches Pilot Programs in Atlanta, Nashville, and Philadelphia to Increase Diversity in Lupus Clinical Research
June 29, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced the launch of three pilot research...
Press Release
Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE and Lupus Nephritis Through North American Trial Network
June 2, 2023
Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic...
News Update
Investigational CAR T Cell Gets Fast Tracked by U.S. FDA
May 1, 2023
The LRA and our clinical arm Lupus Therapeutics are pleased to share good news from Cabaletta Bio, Inc. that...
Posts pagination
◀︎
1
2
3
4
5
▶︎